David A. Siegel Assembly Biosciences, Inc. Transaction History

Two Sigma Advisers, LP

$43.8 Billion
Q2 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.65 - $1.25 $13,130 - $25,250	20,200 Added 155.38%	33,200 $27,000
Q3 2023 Nov 14, 2023	SELL	$0.87 - $1.13 $1,653 - $2,147	-1,900 Reduced 12.75%	13,000 $11,000
Q2 2023 Aug 14, 2023	SELL	$0.81 - $1.15 $14,742 - $20,930	-18,200 Reduced 54.98%	14,900 $17,000
Q1 2023 May 15, 2023	SELL	$0.8 - $1.74 $3,440 - $7,482	-4,300 Reduced 11.5%	33,100 $27,000
Q4 2022 Feb 14, 2023	SELL	$1.09 - $20.4 $29,866 - $558,960	-27,400 Reduced 42.28%	37,400 $48,000
Q3 2022 Nov 14, 2022	SELL	$1.7 - $20.52 $54,230 - $654,588	-31,900 Reduced 32.99%	64,800 $106,000
Q2 2022 Aug 15, 2022	SELL	$1.35 - $2.29 $96,660 - $163,964	-71,600 Reduced 42.54%	96,700 $203,000
Q1 2022 May 16, 2022	SELL	$1.46 - $2.45 $372,300 - $624,750	-255,000 Reduced 60.24%	168,300 $347,000
Q4 2021 Feb 14, 2022	BUY	$2.13 - $3.46 $158,898 - $258,116	74,600 Added 21.39%	423,300 $986,000
Q3 2021 Nov 15, 2021	SELL	$3.14 - $3.9 $1.28 Million - $1.59 Million	-408,500 Reduced 53.95%	348,700 $1.21 Million
Q2 2021 Aug 16, 2021	BUY	$3.8 - $4.56 $201,400 - $241,679	53,000 Added 7.53%	757,200 $2.94 Million
Q1 2021 May 17, 2021	BUY	$4.33 - $6.63 $2.5 Million - $3.84 Million	578,500 Added 460.22%	704,200 $3.24 Million
Q4 2020 Feb 16, 2021	BUY	$4.87 - $17.29 $250,318 - $888,706	51,400 Added 69.18%	125,700 $760,000
Q3 2020 Nov 16, 2020	SELL	$15.08 - $27.04 $168,896 - $302,848	-11,200 Reduced 13.1%	74,300 $1.22 Million
Q2 2020 Aug 14, 2020	BUY	$14.57 - $23.96 $208,351 - $342,628	14,300 Added 20.08%	85,500 $1.99 Million
Q1 2020 May 15, 2020	BUY	$10.27 - $21.23 $11,297 - $23,353	1,100 Added 1.57%	71,200 $1.06 Million
Q4 2019 Feb 14, 2020	SELL	$8.36 - $23.81 $72,732 - $207,147	-8,700 Reduced 11.04%	70,100 $1.43 Million
Q3 2019 Nov 14, 2019	BUY	$9.83 - $14.82 $214,294 - $323,076	21,800 Added 38.25%	78,800 $775,000
Q2 2019 Aug 14, 2019	BUY	$12.9 - $20.8 $735,300 - $1.19 Million	57,000 New	57,000 $769,000
Q2 2018 Aug 14, 2018	SELL	$39.21 - $50.29 $207,813 - $266,537	-5,300 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$41.7 - $64.16 $221,010 - $340,048	5,300 New	5,300 $260,000

Others Institutions Holding ASMB

# of Institutions

Shares Held

16.3K

Call Options Held

Put Options Held

ETF Managers Group, LLC Summit, NJ

16.3K
Shares

$277,028
0.0% of portfolio

View Full List

About ASSEMBLY BIOSCIENCES, INC.

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $822M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

More about ASMB

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account